Leupaxin Antikörper (AA 1-300)
-
- Target Alle Leupaxin (LPXN) Antikörper anzeigen
- Leupaxin (LPXN)
-
Bindungsspezifität
- AA 1-300
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Leupaxin Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Leupaxin protein (1-300AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- Leupaxin (LPXN)
- Andere Bezeichnung
- LPXN (LPXN Produkte)
- Synonyme
- LDPL antikoerper, 4933402K05Rik antikoerper, A530083L21Rik antikoerper, AV278559 antikoerper, MGC140379 antikoerper, leupaxin antikoerper, hypothetical protein antikoerper, Leupaxin antikoerper, LPXN antikoerper, Lpxn antikoerper, lpxn antikoerper, PAAG_03110 antikoerper, PGTG_11441 antikoerper
- Hintergrund
-
Background: Transcriptional coactivator for androgen receptor (AR) and serum response factor (SRF). Contributes to the regulation of cell adhesion, spreading and cell migration and acts as a negative regulator in integrin-mediated cell adhesion events. Suppresses the integrin-induced tyrosine phosphorylation of paxillin (PXN). May play a critical role as an adapter protein in the formation of the adhesion zone in osteoclasts. Negatively regulates B-cell antigen receptor (BCR) signaling.
Aliases: LPXN antibody, LDLPLeupaxin antibody
- UniProt
- O60711
-